Wegovy Dosage Guide: How Much to Take and When (With Chart)
Key TakeawaysWegovy is a prescription medication used for chronic weight management in adults with obesity or overweight conditions.The dosage of Wegovy is gradually [...]
Read MoreMedically reviewed by Alan Lucks | MD, Alan Lucks MDPC Private Practice - New York on December 10th, 2025.
Wegovy is a prescription medication used for chronic weight management in adults with obesity or overweight conditions.
The dosage of Wegovy is gradually increased over 16 to 20 weeks to minimize side effects and improve tolerance.
Typical adult doses start at 0.25 mg weekly and increase to a maintenance dose of 2.4 mg weekly.
Wegovy is administered as a subcutaneous injection once weekly, and consistent timing is important for effectiveness.
If you miss a dose, specific guidelines help you safely resume treatment without doubling doses.
Consulting with a healthcare provider, such as through telehealth services like Doctronic.ai, ensures personalized dosage guidance and ongoing support.
Wegovy, known generically as semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management. It works by regulating appetite and food intake, helping people with obesity or overweight conditions achieve and maintain weight loss.
Because Wegovy affects the digestive system and metabolism, starting at a low dose and gradually increasing it is crucial. This approach helps reduce common side effects like nausea or digestive discomfort, allowing your body to adjust smoothly.
Form |
Strength |
Typical Adult Dose |
Frequency |
Route |
Maximum Daily Dose |
|---|---|---|---|---|---|
Injection |
0.25 mg |
0.25 mg |
Once weekly |
Subcutaneous |
2.4 mg |
Injection |
0.5 mg |
0.5 mg |
Once weekly |
Subcutaneous |
2.4 mg |
Injection |
1 mg |
1 mg |
Once weekly |
Subcutaneous |
2.4 mg |
Injection |
1.7 mg |
1.7 mg |
Once weekly |
Subcutaneous |
2.4 mg |
Injection |
2.4 mg |
2.4 mg |
Once weekly |
Subcutaneous |
2.4 mg |
The treatment begins with a low dose of 0.25 mg injected once weekly. This dose is not intended for weight loss but to help your body get used to the medication. The initiation phase typically lasts four weeks.
After the initial four weeks, the dose is gradually increased every four weeks to the next level: 0.5 mg, then 1 mg, then 1.7 mg, and finally 2.4 mg. This slow increase helps reduce gastrointestinal side effects and improves overall tolerability.
The target maintenance dose is 2.4 mg once weekly. This is the dose shown to be effective for weight loss and long-term management. Some patients may remain on a lower dose if they cannot tolerate the higher dose, but this should be discussed with a healthcare provider.
Adults typically start at 0.25 mg once weekly and increase the dose every four weeks until reaching 2.4 mg weekly. The entire titration period takes about 16 to 20 weeks. After that, the 2.4 mg dose is maintained for ongoing weight management.
It is important to follow your healthcare provider’s instructions closely. If you experience severe side effects, your doctor may adjust your dose or suggest ways to manage symptoms.
If you miss a dose of Wegovy, take it as soon as you remember if it is within five days of the missed dose. If more than five days have passed, skip the missed dose and take the next dose on your regular schedule. Do not take two doses at once to make up for a missed injection.
Maintaining a consistent weekly schedule is important for the medication’s effectiveness. Setting reminders or using a weekly calendar can help keep you on track.
Patients with moderate kidney or liver impairment should use Wegovy cautiously. Dose adjustments may be necessary, but specific guidelines depend on individual health status. Always consult your healthcare provider before making changes.
Since Wegovy can cause nausea, vomiting, or diarrhea, patients with pre-existing gastrointestinal problems should be monitored closely. Dose titration may be slowed or paused to minimize side effects.
An overdose of Wegovy can increase the risk of severe side effects, including nausea, vomiting, and pancreatitis. If an overdose is suspected, seek medical attention immediately.
Warnings include the potential for thyroid tumors, including cancer, in animal studies. Patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should avoid Wegovy.
Follow the prescribed dosing schedule and do not adjust doses without consulting your doctor.
Store Wegovy in the refrigerator and protect it from light.
Use the injection at the same time each week for best results.
Report any side effects to your healthcare provider promptly.
Use telehealth services like Doctronic.ai to get quick answers and connect with doctors for personalized advice.
Managing your Wegovy dosage and treatment plan can be complex. Personalized guidance from healthcare professionals is invaluable. Doctronic offers AI-powered, direct-to-patient care that combines the latest medical research with personalized attention. You can access free AI doctor visits anytime on their website, and if needed, schedule affordable telehealth video visits with licensed doctors across all 50 states.
Using Doctronic.ai ensures you get accurate, up-to-date information tailored to your health needs. This includes detailed dosage advice, side effect management, and ongoing support for your weight management journey.
Wegovy is a powerful tool for weight management when used correctly. The key to success lies in following the recommended dosage schedule, starting low and titrating up to the maintenance dose. This approach minimizes side effects and maximizes benefits.
Always work closely with your healthcare provider to monitor your progress and adjust your treatment as needed. For convenient, expert support, consider telehealth options like Doctronic, which can provide personalized care without the hassle of in-person visits.

Many patients start noticing weight loss within the first few weeks of treatment, but significant results typically appear after reaching the maintenance dose around 16 to 20 weeks.
Wegovy is approved for weight management and is sometimes used in people with type 2 diabetes. However, dosage and safety should be managed by your healthcare provider.
Mild side effects often improve over time. If side effects are severe or persistent, contact your healthcare provider. They may adjust your dosage or suggest supportive treatments.
Wegovy is currently approved only for adults. Pediatric use has not been established and should only be considered under strict medical supervision.
Stopping Wegovy abruptly may lead to weight regain. Discuss any plans to stop or adjust your medication with your healthcare provider to develop a safe plan.
Doctronic.ai provides AI-powered answers and access to doctors who can help you with personalized dosage advice and treatment support.
Key TakeawaysWegovy is a prescription medication used for chronic weight management in adults with obesity or overweight conditions.The dosage of Wegovy is gradually [...]
Read More